Stock Earnings

Question 1

Viridian Therapeutics Incの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Viridian Therapeutics Incの総資産は$742で、純lossは$-269です。

Question 2

VRDNの主要な財務比率は何ですか？

Accepted Answer

Viridian Therapeutics Incの流動比率は10.6、純利益率は0、1株当たり売上高は$0です。

Question 3

Viridian Therapeutics Incの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Viridian Therapeutics Inc largest revenue segment is Monoclonal Antibody, at a revenue of 302,000 in the most earnings release.For geography, United States is the primary market for Viridian Therapeutics Inc, at a revenue of 302,000.

Question 4

Viridian Therapeutics Incは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、Viridian Therapeutics Incの純lossは$-269です。

Question 5

Viridian Therapeutics Incに負債はありますか？

Accepted Answer

yes、Viridian Therapeutics Incの負債は70です。

Question 6

Viridian Therapeutics Incの発行済株式数は何株ですか？

Accepted Answer

Viridian Therapeutics Incの総発行済株式数は80.99株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	1	2	1
Revenue Growth (YoY)	--	--	-100%	-50%	100%	-75%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	67	61	94	35	25	13
Research & Development	304	237	159	100	56	27
Operating Expenses	371	299	254	136	82	41
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-344	-269	-237	-129	-79	-110
Income Tax Expense	--	--	--	--	--	--
Net Income	-344	-269	-237	-129	-79	-110
Net Income Growth	51%	14%	84%	63%	-28%	168%
Shares Outstanding (Diluted)	81.59	67.88	44.75	32.09	11.92	3.56
Shares Change (YoY)	28%	52%	39%	169%	235%	70%
EPS (Diluted)	-4.21	-3.97	-5.31	-4.05	-6.66	-31.1
EPS Growth	18%	-25%	31%	-39%	-79%	55%
Free Cash Flow	-309	-232	-185	-94	-54	-29
Free Cash Flow Per Share	-3.78	-3.41	-4.13	-2.92	-4.53	-8.14
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	-13,400%	-3,950%	-4,000%
Profit Margin	0%	0%	0%	-12,900%	-3,950%	-11,000%
Free Cash Flow Margin	0%	0%	0%	-9,400%	-2,700%	-2,900%
EBITDA	-371	-299	-254	-134	-79	-40
EBITDA Margin	0%	0%	0%	-13,400%	-3,950%	-4,000%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-371	-299	-254	-134	-79	-40
EBIT Margin	0%	0%	0%	-13,400%	-3,950%	-4,000%
Effective Tax Rate	--	--	--	--	--	--

Viridian Therapeutics Inc (VRDN) Price

VRDN Stock Price Chart

VRDN Income

Follow-Up Questions